Identification of KX2‐391 as an inhibitor of HBV transcription by a recombinant HBV‐based screening assay
Sign Up to like & getrecommendations! Published in 2017 at "Antiviral Research"
DOI: 10.1016/j.antiviral.2017.06.005
Abstract: Abstract Antiviral therapies for chronic hepatitis B virus (HBV) infection that are currently applicable for clinical use are limited to nucleos(t)ide analogs targeting HBV polymerase activity and pegylated interferon alpha (PEG‐IFN). Towards establishing an effective… read more here.
Keywords: anti hbv; hbv; tubulin polymerization; recombinant hbv ... See more keywords